Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
- PMID: 1357245
- DOI: 10.1016/0140-6736(92)92686-a
Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
Abstract
Nitric oxide (NO) has vasodilatory effects on the pulmonary vasculature in adults and animals. We examined the effects on systemic oxygenation and blood pressure of inhaling up to 80 parts per million by volume of NO at FiO2 0.9 for up to 30 minutes by 6 infants with persistent pulmonary hypertension of the newborn (PPHN). In all infants this treatment rapidly and significantly increased preductal oxygen saturation (SpO2); in 5 infants postductal SpO2 and oxygen tensions also increased. Inhalation of NO did not cause systemic hypotension or raise methaemoglobin. These data suggest that low levels of inhaled NO have an important role in the reversal of hypoxaemia due to PPHN.
Comment in
-
Simple method for monitoring concentration of inhaled nitric oxide.Lancet. 1992 Nov 7;340(8828):1167. doi: 10.1016/0140-6736(92)93201-w. Lancet. 1992. PMID: 1359248 No abstract available.
-
Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects.Lancet. 1992 Dec 19-26;340(8834-8835):1545. doi: 10.1016/0140-6736(92)92796-i. Lancet. 1992. PMID: 1361626 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
